Sonata Capital Group Inc Amgen Inc Transaction History

Sonata Capital Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$219.27 - $242.57 $16,445 - $18,192	-75 Reduced 8.22%	837 $202,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $181,378 - $207,571	912 New	912 $205,000
Q3 2021 Nov 08, 2021	SELL	$212.27 - $248.7 $193,590 - $226,814	-912 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$197.81 - $242.74 $180,402 - $221,378	912 New	912 $215,000
Q1 2020 Apr 27, 2020	SELL	$182.24 - $241.7 $168,389 - $223,330	-924 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$189.21 - $243.2 $174,830 - $224,716	924 New	924 $223,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Sonata Capital Group Inc, based on Form 13F filings with the SEC.

Stay updated on Sonata Capital Group Inc with notifications on news.